SkinScreener
SkinScreener (medaia GmbH) is an Austrian digital health company that markets a CE-certified Class IIa AI smartphone app for skin cancer risk assessment, serving individual consumers across 17+ European countries and enterprise customers in insurance, construction, and pharmaceutical sectors.
- Company typePrivate
- Founded2019
- HeadquartersGraz, Austria
- Headcount1–10
- GTM typeB2B and B2C
- OfferingSoftware
What SkinScreener does
SkinScreener (operated by medaia GmbH, headquartered in Graz, Austria) develops a CE-certified Class IIa medical device smartphone application that uses proprietary convolutional and region-proposal neural networks to assess the risk of skin cancer from photographs of skin lesions. The product targets individual consumers seeking proactive skin health monitoring as well as enterprise customers — notably health insurers (Merkur Versicherung, Wiener Städtische Versicherung), construction and waste-management firms with outdoor workforces (Swietelsky, Saubermacher), and pharmaceutical companies (MSD, Pelpharma). The algorithms were clinically validated at the Medical University of Graz on 238 patients and 1,171 lesions, achieving 95.35% sensitivity (analyze) and 96.4% sensitivity (detect), with results published in PLOS ONE.
The company monetizes through three channels: consumer subscriptions priced at €24.99 for 6 months or €39.99 for 12 months (with a free first scan as acquisition hook); custom-priced enterprise plans for corporate wellness programs targeting occupational UV exposure; and revenue-share or licensing arrangements with health insurance partners that integrate the app into their policyholder offerings. The app is available on iOS App Store and Google Play Store across 17 European countries plus New Zealand, and the company has reached 300,000+ downloads, 800,000+ scans, and 500,000+ images analyzed.
The technology stack is built around an in-house dual-algorithm system ('analyze' for real-time whole-image classification and 'detect' for bounding-box lesion detection), trained on 18,384 labeled images across 47 subcategories spanning benign, anatomical, non-neoplastic, precancerous, and malignant classifications, mapped to low/medium/high risk outputs. The company holds ISO 13485 quality management certification and Austrian medical device registration 10965455. The 11-50 person team is led by CEO Albin Skasa and founder/medical advisor Dr. Michael Tripolt, a dermatologist, with active engineering, regulatory, and usability functions.
SkinScreener firmographics
Firmographics- Name
- SkinScreener
- Legal name
- medaia GmbH
- Website
- https://skinscreener.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- SkinScreener (medaia GmbH) is an Austrian digital health company that markets a CE-certified Class IIa AI smartphone app for skin cancer risk assessment, serving individual consumers across 17+ European countries and enterprise customers in insurance, construction, and pharmaceutical sectors.
- Ownership category
- akta.pro rank
SkinScreener industry classification
Industry- Product category
- Dermatology AI Software
- NAICS
- Hair, Nail, and Skin Care Services (81211)
- akta.pro primary industry
- Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
- akta.pro secondary industries
- Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF), Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning) (CRABAKAI)
Keywords
Where SkinScreener is headquartered
LocationHeadquarters
- HQ city
- Graz
- HQ country
- Austria
- HQ region
- Europe
Offices1 record
Markets served
SkinScreener business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Consumer App Subscriptions: Individual consumers purchase subscriptions (6-month or annual) or individual scans through the app. First scan is free. Subscriptions provide unlimited scans, UV index access, and skin check reminders. Pricing: €24.99/6 months or €39.99/year.
- Enterprise/Corporate Health Plans: Custom enterprise plans for companies offering SkinScreener as part of corporate wellness initiatives. Includes unlimited scans, flexible employee access, reporting, onboarding support, UV index, and reminders. Tailored for outdoor worker industries and insurance partnerships.
- Insurance Integration: Partnerships with health insurance providers (Merkur, Wiener Städtische) who integrate SkinScreener into their customer apps, potentially as covered preventive care benefit.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | 6-month subscription with unlimited scans |
| Subscription | Annual | Annual subscription with unlimited scans (popular plan) |
| Subscription | Multi-year contract | Custom enterprise plan for companies |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
SkinScreener product offering
Product offeringCore offering
SkinScreener is a CE-certified Class IIa medical device mobile application that uses AI-powered neural networks to assess the risk of skin cancer from smartphone photographs of moles and skin lesions. It provides instant risk classification (low, medium, high) to support early skin cancer detection, with optional teledermatological review. The product is offered via direct-to-consumer subscriptions and enterprise plans for corporate wellness and occupational health programs.
Product overview
SkinScreener is a single unified mobile health application for skin cancer prevention. The core product is the SkinScreener app (available on iOS and Android) which uses AI-powered image analysis to assess skin lesion risk. The product portfolio includes individual scan purchases, subscription plans (Pro Plan at €24.99/6 months and Yearly Plan at €39.99/year) offering unlimited scans with features like UV index access and reminders, and an Enterprise Plan for corporate health programs. Key features include AI-based image analysis, visual body mapping for tracking, personal scan archive, and UV index monitoring. The app is classified as a Class IIa medical device under EU MDR.
Differentiator
Problem solved
Functional benefit
Products and services
- SkinScreener App CE-certified Class IIa medical device smartphone app that uses artificial intelligence to assess the risk of skin cancer from photos of moles and skin lesions. Users photograph suspicious skin areas and receive instant AI-powered risk assessments (low, medium, or high) to support early skin cancer detection. Targets adults seeking proactive skin health monitoring.
- SkinScreener Pro Plan (6 Months) 6-month consumer subscription offering unlimited skin scans, UV index access, skin check reminders, and instant AI risk assessments for €24.99 billed every 6 months. Targeted at individual users.
- SkinScreener Yearly Plan Annual consumer subscription offering unlimited skin scans, UV index access, skin check reminders, and instant AI risk assessments for €39.99 billed yearly. Targeted at individual users.
- SkinScreener Enterprise Plan Custom corporate health solution offering unlimited scans, flexible employee access, reporting, onboarding support, UV index access, skin check reminders, and latest skin cancer information. Targeted at companies, particularly those with outdoor workers.
Quantifiable outcome
- 95% clinical accuracy in detecting skin cancer risk (vs. 80% sensitivity reported for other smartphone apps in meta-analyses)
- +3 more outcomes
Companies that use SkinScreener
Customer profileNamed customers7 records
Segments2 records
Ideal customer profiles3 records
SkinScreener technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature4 records
SkinScreener partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core, strategic and minor.
- Medizinische Universität GrazcoreClinical research partnership for AI algorithm validation. Study conducted at Medical University of Graz with 238 patients and 1,171 lesions. Published in PLOS ONE peer-reviewed journal. Ongoing collaboration for post-market surveillance and AI development.
- Technische Universität GrazcoreAcademic partnership with Graz University of Technology for technical expertise in engineering and digital innovation supporting AI development.
- Merkur VersicherungcoreHealth insurance provider integrating SkinScreener directly into their customer app as part of digital health offerings for preventive screenings.
- Wiener Städtische VersicherungcoreMajor Austrian health insurer emphasizing early detection of skin cancer for policyholders through app integration.
- Krebshilfe ÖsterreichstrategicPartnership with Austria's leading cancer non-profit for skin cancer prevention awareness, research support, and patient education.
- Human Technology StyriastrategicBusiness cluster connecting companies, research institutions, and healthcare providers in life sciences sector.
- PelpharmastrategicAustrian pharmaceutical company specializing in dermatology and skin health. Focus on innovative therapies and prevention.
- 5-HT Chemistry & HealthminorPart of Digital Hub Initiative of German Federal Ministry for Economic Affairs. Connects startups, corporations, and investors in chemistry, health, and sustainability.
- MSDstrategicGlobal healthcare company prioritizing employee health. Uses SkinScreener for internal employee wellness and skin cancer prevention awareness.
- Swietelsky AG ÖsterreichstrategicAustria's third largest construction company (~12,000 employees) using SkinScreener for occupational health of outdoor workers exposed to UV radiation.
- Saubermacher Dienstleistungs AGminorLeading Austrian waste management company using SkinScreener for employee wellness programs.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
SkinScreener competitors and assessment
Company assessmentDirect peers
- Miiskin: Denmark-based Miiskin provides AI mole-tracking and skin self-monitoring apps for consumers and enterprises, directly competing with SkinScreener in mole mapping, body photography, and dermatology workflow tools.
- Aysa (VisualDx): VisualDx's Aysa app provides AI-driven skin condition analysis for consumers and clinicians, comparable to SkinScreener in smartphone-based dermatology screening with similar freemium-to-subscription GTM and clinical-evidence-led positioning.
- SkinVision: Amsterdam-based SkinVision is a direct competitor offering AI-powered smartphone skin cancer risk assessment with CE marking and insurance partnerships across Europe, targeting the same B2C subscription and B2B wellness channels.
- FotoFinder (MoleScope): German MoleScope/FotoFinder offers smartphone-based dermatoscopy attachments and AI skin analysis used by dermatologists and patients, overlapping with SkinScreener in AI skin lesion risk assessment though with a hardware component.
- Skin Analytics: UK-based Skin Analytics offers AI dermatology triage tools (DERM) deployed in NHS pathways with Class IIa CE marking, a direct peer in regulated AI skin cancer risk assessment serving healthcare providers and insurers.
Emerging players
- SkinIO: SkinIO is a US-based emerging player in AI skin imaging for dermatology practices and clinical trials, comparable in computer-vision skin lesion analysis but primarily serving the clinical research market rather than consumer subscriptions.
- DermaSensor: DermaSensor is an FDA-cleared handheld spectroscopic skin cancer evaluation device for primary-care physicians, an emerging peer in regulated AI-assisted skin cancer detection targeting clinicians rather than consumer smartphones.
Regional players
- Skinive: Skinive is an EU/CIS-region AI skin health app with CE marking offering similar smartphone-based dermatology risk assessment, a regional peer overlapping in product but with weaker enterprise/insurance channel development.
Others
- Doctor Mole: Doctor Mole was an early smartphone-based mole monitoring app; while less active, it represents an adjacent consumer health/skin-tracking category that competes for the same DIY dermatology user attention as SkinScreener.
Broad incumbents
- Google DermAssist (Derm): Google's DermAssist is a CE-marked AI dermatology assistant built into Google Search, offering free AI skin condition analysis — a broad-incumbent threat that could undercut SkinScreener's consumer subscription economics through platform distribution.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
SkinScreener social profiles
Digital presenceSkinScreener compliance and trust
Trust signalCompliance5 records
SkinScreener financial estimates
Financial estimateRevenue estimate
Valuation estimate
SkinScreener leadership team
Management profileNumber of profiles
Profiles10 records
SkinScreener funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SkinScreener M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SkinScreener
What does SkinScreener do?
SkinScreener is a CE-certified Class IIa medical device mobile application that uses AI-powered neural networks to assess the risk of skin cancer from smartphone photographs of moles and skin lesions. It provides instant risk classification (low, medium, high) to support early skin cancer detection, with optional teledermatological review. The product is offered via direct-to-consumer subscriptions and enterprise plans for corporate wellness and occupational health programs.
Is SkinScreener a public or private company?
SkinScreener is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was SkinScreener founded?
SkinScreener was founded in 2019. It employs 1 to 10 people.
Where is SkinScreener based?
SkinScreener is headquartered in Graz, Austria, in the Europe region.
How does SkinScreener make money?
Three revenue lines are on record. Consumer App Subscriptions are the primary driver. The others are enterprise/Corporate Health Plans and insurance Integration.
Who are SkinScreener's main competitors?
Direct peers on record are Miiskin, Aysa (VisualDx), SkinVision, FotoFinder (MoleScope) and Skin Analytics. Emerging players are SkinIO and DermaSensor. Skinive is listed as a regional player. Doctor Mole is listed as an others. Google DermAssist (Derm) is listed as a broad incumbent.
Does SkinScreener have an API?
No public API is recorded for SkinScreener.
What industry is SkinScreener in?
SkinScreener's product category is Dermatology AI Software. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare, with a secondary code of CRADAMAF, Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal). Its NAICS code is 81211.